Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth.
PURPOSE: This phase II trial is studying how well temsirolimus works in treating patients
with advanced liver cancer and cirrhosis.